ADX-47273
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
(S)-(4-fluorophenyl)-(3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]piperidin-1-yl)methanone
|
|
Identifiers | |
CAS Number | 851881-60-2 851881-59-9 (R isomer), 837413-22-6 (racemate) |
PubChem | CID: 11383075 |
IUPHAR/BPS | 1420 |
ChemSpider | 9557988 |
ChEMBL | CHEMBL381055 |
Chemical data | |
Formula | C20H17F2N3O2 |
Molecular mass | 369.364 g/mol |
|
|
|
|
(verify) |
ADX-47273 is a research pharmaceutical developed by Addex Therapeutics which acts as a positive allosteric modulator (PAM) selective for the metabotropic glutamate receptor subtype mGluR5.[1][2] It has nootropic and antipsychotic effects in animal studies,[3] and has been used as a lead compound to develop improved derivatives.[4]
See also
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Oxadiazoles
- MGlu5 receptor agonists
- Nervous system drug stubs